Ocaña, A., Amir, E., & Pandiella, A. (2018). Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: Understanding clinical trial results. Oncotarget.
Citação norma ChicagoOcaña, Alberto, Eitan Amir, and Atanasio Pandiella. "Dual Targeting of HER2-positive Breast Cancer With Trastuzumab Emtansine and Pertuzumab: Understanding Clinical Trial Results." Oncotarget 2018.
Citação norma MLAOcaña, Alberto, Eitan Amir, and Atanasio Pandiella. "Dual Targeting of HER2-positive Breast Cancer With Trastuzumab Emtansine and Pertuzumab: Understanding Clinical Trial Results." Oncotarget 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.